BCom CA MAICD
Mr Mitchell has extensive international healthcare and finance experience. Mr Mitchell is a qualified Charted Accountant with 27 years’ experience (until March 2017) as Chief Financial Officer and Company Secretary of ASX-listed Cochlear Limited, a world leading medical device developer, manufacturer and seller. Cochlear has direct operations in more than 20 countries, with over 3,000 employees. Mr Mitchell was a key member of Cochlear’s executive team responsible for the setting and execution of the company’s growth strategy from its listing in 1995, when annual revenue was $70 million.
Mr Mitchell currently holds non-executive director roles with ASX-listed healthcare companies, Sonic Healthcare (since September 2017), Sirtex Medical Limited (since April 2017) and Osprey Medical Inc. (since July 2012). He is also a member of the Australian Board of Taxation and a director of South East Sydney Local Health District and a member of the NSW Government’s Medical Device Fund.
He has previously performed roles with a number of industry and government committees, including the Group of 100 (Australia’s peak body for senior finance executives), and Chairman, Standing Committee (Accounting and Audit), for the Australian Securities and Investments Commission (ASIC).
Mr Mitchell was appointed as a director of QBiotics Group on 1 November 2017.